Leprosy News and Research

Latest Leprosy News and Research

Thalomid gives hope for blood cancer sufferers

Drug company Celgene says it has halted a pivotal-stage trial of its Thalomid drug earlier than expected after the drug was shown to dramatically limit the progress of the blood cancer multiple myeloma.

9 Jan 2006

UCLA examines disease-versus-disease interactions

The knowledge that one disease may prevent the onset of another is not new. For example, the discovery that cowpox vaccines can prevent smallpox dates back to 1798.

5 Jan 2006

A breakthrough in R&D for neglected diseases

A dramatic sea-change in research into ten so-called "neglected diseases," such as malaria, leprosy and sleeping sickness, could result in at least eight new drugs being developed by 2010.

12 Sep 2005

Discovery of gene that controls the speed at which patients develop tuberculosis

Scientists at the Research Institute of the McGill University Health Centre (RI MUHC) have discovered a gene that controls the speed at which patients develop tuberculosis--the first time such a gene has been discovered for this disease.

16 Aug 2005

What caused leprosy?

What caused leprosy - a widely dreaded disease in medieval Europe - to fade from the scene? By the 16th century, the scourge had practically disappeared there.

2 Aug 2005

Leprosy microbes lead scientists to immune discovery

With the unusual opportunity that human leprosy infections provide for study of human immune responses, scientists have discovered how the body's early warning system prompts a rapid immune response by two separate armies of defensive cells.

29 May 2005

Researchers show protein's role in stopping bacterial-induced inflammation

In findings that could have implications for autoimmune disorders and drug-resistant bacterial infections, researchers at the University of California, San Diego (UCSD) School of Medicine have identified a key protein involved in the appropriate shut-down of inflammation following an immune response to invading pathogens.

28 Apr 2005

African genome research given impetus

Millions of victims in Africa, die each year from preventable diseases like tuberculosis and malaria and researchers say only a relatively small proportion of money is spent on developing vaccines, much more is spent on drugs aimed at tackling diseases more prevalent among rich, Western consumers.

21 Mar 2005

Abandoned bones suggest TB wiped out leprosy in battle of killer diseases

The spread of tuberculosis may have killed off leprosy in Europe in the Middle Ages, according to research published in the latest issue of the Royal Society Proceedings B.

8 Feb 2005

Shakespeare may have had syphilis

Shakespeare’s name usually inspires thoughts of kings, fairies, lovers, wars and poetic genius--not syphilis. However, some passages in his plays and sonnets indicate that the Bard may have suffered from one or more venereal infections, according to an article in the Feb. 1 issue of Clinical Infectious Diseases, now available online.

10 Jan 2005

Dramatic changes in the way the FDA address patient safety are needed

Food and Drug Administration policies prevent pharmaceutical manufacturers from informing patients about potentially fatal toxicities that occur with some cancer drugs -- policies that should be revised immediately, according to Northwestern University researchers.

20 Dec 2004

Thalidomide shows promise in fighting myeloma

Thalidomide, a drug often used to treat symptoms of leprosy and in testing to fight HIV, is now demonstrating activity in fighting a common cancer that occurs in bone marrow, myeloma.

6 Dec 2004

Rifampicin can prevent the formation of protein fibrils associated with Parkinson's disease

Researchers at the University of California, Santa Cruz, have shown that rifampicin, an antibiotic used to treat leprosy and tuberculosis, can prevent the formation of protein fibrils associated with the death of brain cells in people with Parkinson's disease. The drug also dissolved existing fibrils in laboratory tests.

29 Nov 2004

Crohn’s disease may be caused by same bacterium that causes Paratuberculosis or Johne’s disease in cattle, sheep, and goats

A study in this week’s issue of THE LANCET suggests that Crohn’s disease may be caused by Mycobacterium avium subspecies paratuberculosis (MAP), the same bacterium that causes a similar intestinal disorder (known as Paratuberculosis or Johne’s disease) in cattle, sheep, and goats.

17 Sep 2004

Cell biologists may have discovered a new effective therapy for psoriasis

About two million Germans suffer from psoriasis (from the Greek psora meaning ‘itching, scratching’). In this incurable disease the regeneration of the epidermis is speeded up enormously: whereas it normally renews itself in just under four weeks, this period is cut to four to seven days in psoriasis patients.

16 Aug 2004

Final push towards elimination of Leprosy

It currently affects over 1 million people in Africa, Asia, South America, and the Pacific; and WHO estimates that between 2 and 3 million individuals are permanently disabled as a result of it. Although all the registered cases are on treatment, it is estimated that during the period 2000–2005, about 2.5 million people affected by leprosy need to be detected and treated.

29 Jul 2004

Diseases are being neglected in wake of HIV/AIDS, TB and Malaria

Millions of the world's poorest people are suffering needlessly from diseases that are being neglected because of the emphasis given to the "big 3" killers, HIV/AIDS, TB and Malaria, says Professor David Molyneux of the Liverpool School of Tropical Medicine.

29 Jul 2004

Skeletal remains of 3,160 individuals reveal changing status of cancer in Europe across the centuries

Cancer incidence rates in the developed world are increasing each year and developing countries are also now showing an increased incidence of the disease.

8 Jul 2004

Five million village doctors in rural China to be re-trained

A memorandum which is to lead to the re-training of five million village doctors in rural China is to be signed on 23 May in Beijing, China. The memorandum goes back to the initiative of Terence Ryan, Professor of Dermatology at the University of Oxford, who has been instrumental in drawing it up and will participate in the signing.

14 May 2004

New chink in the cellular armor of tuberculosis (TB) and leprosy

The family of bacteria that causes tuberculosis (TB) and leprosy are notoriously sturdy. And although the diseases they cause have been held in check for the past 50 years by antibiotics, some strains are becoming increasingly resistant to existing therapy.

10 May 2004